Search

Author/Creator Molnar, Judit

1. Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia. Issue 12 (11th July 2022)

Authors:
Furze, Rebecca C.; Molnar, Judit; Parr, Nigel J.; Ahmad, Faiz; Henry, Yvette; Howe, David; Singh, Rajendra; Toal, Martin; Bassil, Anna K.; Bernard, Sharon G.; Davis, Robert P.; Gibson, Adele; Maller, N. Claire; Sharp, Catriona; Tough, David F.; Prinjha, Rab K.; Lewis, Huw D.
Other Names:
Wong Ian guestEditor.; Dewildt Saskia guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 12(2022)
Page Start:
5238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P0514USP30 INHIBITOR ATTENUATES PROGRESSIVE FIBROSIS IN ISCHEMIA INDUCED CHRONIC KIDNEY DISEASE (CKD), EVEN AFTER DELAYED TREATMENT INITIATION AFTER INJURY. (6th June 2020)

Authors:
Bedford, David; Wright, Jamie; Rong, Song; Thompson, Paul; Shushakova, Nelli; Schmidt, Sonja; Gueler, Faikah; Molnar, Judit
Journal:
Nephrology dialysis transplantation
Issue:
Volume 35(2020)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗